ID3 and neoplasm: These results show that, in addition to being required for the anti-tumour activity of KCs, expression of ID3 is also sufficient to endow mouse and human macrophages with a potent, local and innate anti-tumour activity, in vitro and in vivo, against epithelial and melanocytic cancers (Extended Data Fig. 10e).